Evidence map›Paper›PMID 31104993›Full record

ArticleBioorganic & medicinal chemistry letters2019

First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors.

Yangxiong Li, Jessi J Gardner, Katherine R Fortney, Inga V Leus, Vincent Bonifay, Helen I Zgurskaya, Alexandre A Pletnev, Sheng Zhang, Zhong-Yin Zhang, Gordon W Gribble and 2 more

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Compound Uptake intoACS infectious diseases · 2021
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yangxiong LiInstitute for Natural Products Applications and Research Technologies, Norman, OK 73019-5251, United States; Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.
Jessi J GardnerInstitute for Natural Products Applications and Research Technologies, Norman, OK 73019-5251, United States; Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.
Katherine R FortneyDepartments of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Inga V LeusDepartment of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.
Vincent BonifayDepartment of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.
Helen I ZgurskayaDepartment of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.
Alexandre A PletnevDepartment of Chemistry, Dartmouth College, Hanover New Hampshire, 03755, United States.
Sheng ZhangBiochemistry, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Zhong-Yin ZhangBiochemistry, Indiana University School of Medicine, Indianapolis, IN 46202, United States; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States; The Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, United States.
Gordon W GribbleDepartment of Chemistry, Dartmouth College, Hanover New Hampshire, 03755, United States.
Stanley M SpinolaDepartments of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, United States; Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, United States; Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Adam S DuerfeldtInstitute for Natural Products Applications and Research Technologies, Norman, OK 73019-5251, United States; Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States. Electronic address: adam.duerfeldt@ou.edu.
Dartmouth College · USIndiana University School of MedicineIndiana University – Purdue University Indianapolis · USPurdue University West Lafayette · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Predictive Models for Small-Molecule Accumulation in Gram-Negative BacteriaR01AI136795 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TAN, DEREK S, ZGURSKAYA, HELEN I · 2018 to 2022
$6.5M
Development of SHP2 inhibitors for targeted anti-cancer therapyR01CA207288 · NCI · PURDUE UNIVERSITY · PI ZHANG, ZHONG-YIN · 2017 to 2021
$2.3M
NCATS NIH HHS UL1 TR001108NCI NIH HHS R01 CA207288NIAID NIH HHS R01 AI136795
6 · The paper itself

Abstract

Genetic activation of the bacterial two-component signal transduction system, CpxRA, abolishes the virulence of a number of pathogens in human and murine infection models. Recently, 2,3,4,9-tetrahydro-1H-carbazol-1-amines were shown to activate the CpxRA system by inhibiting the phosphatase activity of CpxA. Herein we report the initial structure-activity relationships of this scaffold by focusing on three approaches 1) A-ring substitution, 2) B-ring deconstruction to provide N-arylated amino acid derivatives, and 3) C-ring elimination to give 2-ethylamino substituted indoles. These studies demonstrate that the A-ring is amenable to functionalization and provides a promising avenue for continued optimization of this chemotype. Further investigations revealed that the C-ring is not necessary for activity, although it likely provides conformational constraint that is beneficial to potency, and that the (R) stereochemistry is required at the primary amine. Simplification of the scaffold through deconstruction of the B-ring led to inactive compounds, highlighting the importance of the indole core. A new lead compound 26 was identified, which manifests a ∼30-fold improvement in CpxA phosphatase inhibition over the initial hit. Comparison of amino and des-amino derivatives in bacterial strains differing in membrane permeability and efflux capabilities demonstrate that the amine is required not only for target engagement but also for permeation and accumulation in Escherichia coli.

Indexed as

AnimalsCarbazolesHumansMiceStructure-Activity Relationship2,3,4,9-tetrahydro-1H-carbazol-1-amineCarbazolesAntibacterialCpxRADrug discoveryEffluxMedicinal chemistryPermeabilitySensory kinaseTwo-component system

Identifiers

PMID31104993
PMCPMC6594187
OpenAlexW2944694761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.